An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial

BackgroundPeople living with HIV often struggle with mental health comorbidities that lower their antiretroviral therapy (ART) adherence. There is growing evidence that depression treatment may improve ART adherence and result in improved HIV outcomes. Given that mental healt...

Full description

Bibliographic Details
Main Authors: Proscovia Nabunya, Patricia Cavazos-Rehg, James Mugisha, Erin Kasson, Olive Imelda Namuyaba, Claire Najjuuko, Edward Nsubuga, Lindsey M Filiatreau, Abel Mwebembezi, Fred M Ssewamala
Format: Article
Language:English
Published: JMIR Publications 2024-03-01
Series:JMIR Research Protocols
Online Access:https://www.researchprotocols.org/2024/1/e54635
_version_ 1797268255801344000
author Proscovia Nabunya
Patricia Cavazos-Rehg
James Mugisha
Erin Kasson
Olive Imelda Namuyaba
Claire Najjuuko
Edward Nsubuga
Lindsey M Filiatreau
Abel Mwebembezi
Fred M Ssewamala
author_facet Proscovia Nabunya
Patricia Cavazos-Rehg
James Mugisha
Erin Kasson
Olive Imelda Namuyaba
Claire Najjuuko
Edward Nsubuga
Lindsey M Filiatreau
Abel Mwebembezi
Fred M Ssewamala
author_sort Proscovia Nabunya
collection DOAJ
description BackgroundPeople living with HIV often struggle with mental health comorbidities that lower their antiretroviral therapy (ART) adherence. There is growing evidence that depression treatment may improve ART adherence and result in improved HIV outcomes. Given that mental health services are severely underequipped in low-resource settings, including in Uganda, new solutions to increase access to mental health care and close the treatment gap are urgently needed. This protocol paper presents the Suubi-Mhealth study, which proposed to develop a mobile health (mHealth) intervention for use among Ugandan youths (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. ObjectiveThe proposed study is guided by the following objectives: (1) to develop and iteratively refine an intervention protocol for Suubi-Mhealth based on formative work to understand the needs of youths living with HIV; (2) to explore the feasibility and acceptability of Suubi-Mhealth on a small scale to inform subsequent refinement; (3) to test the preliminary impact of Suubi-Mhealth versus a waitlist control group on youths’ outcomes, including depression and treatment adherence; and (4) to examine barriers and facilitators for integrating Suubi-Mhealth into health care settings. MethodsYouths will be eligible to participate in the study if they are (1) 14-17 years of age, (2) HIV-positive and aware of their status, (3) receiving care and ART from one of the participating clinics, and (4) living within a family. The study will be conducted in 2 phases. In phase 1, we will conduct focus group discussions with youths and health care providers, for feedback on the proposed intervention content and methods, and explore the feasibility and acceptability of the intervention. In phase II, we will pilot-test the preliminary impact of the intervention on reducing depression and improving ART adherence. Assessments will be conducted at baseline, 1-, 2-, and 6-months post intervention completion. ResultsParticipant recruitment for phase 1 is completed. Youths and health care providers participated in focus group discussions to share their feedback on the proposed Suubi-Mhealth intervention content, methods, design, and format. Transcription and translation of focus group discussions have been completed. The team is currently developing Suubi-Mhealth content based on participants’ feedback. ConclusionsThis study will lay important groundwork for several initiatives at the intersection of digital therapeutics, HIV treatment, and mental health, especially among sub-Saharan African youths, as they transition through adolescence and into adult HIV care settings. Trial RegistrationClinicalTrials.gov NCT05965245; https://clinicaltrials.gov/study/NCT05965245 International Registered Report Identifier (IRRID)DERR1-10.2196/54635
first_indexed 2024-04-25T01:29:35Z
format Article
id doaj.art-e4dda3c29161495292c5f3bcf144e258
institution Directory Open Access Journal
issn 1929-0748
language English
last_indexed 2024-04-25T01:29:35Z
publishDate 2024-03-01
publisher JMIR Publications
record_format Article
series JMIR Research Protocols
spelling doaj.art-e4dda3c29161495292c5f3bcf144e2582024-03-08T13:30:51ZengJMIR PublicationsJMIR Research Protocols1929-07482024-03-0113e5463510.2196/54635An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled TrialProscovia Nabunyahttps://orcid.org/0000-0002-9088-5839Patricia Cavazos-Rehghttps://orcid.org/0000-0003-3352-1198James Mugishahttps://orcid.org/0000-0003-2084-8693Erin Kassonhttps://orcid.org/0009-0008-7120-5050Olive Imelda Namuyabahttps://orcid.org/0009-0002-0460-2116Claire Najjuukohttps://orcid.org/0009-0007-1911-0508Edward Nsubugahttps://orcid.org/0009-0005-0765-5186Lindsey M Filiatreauhttps://orcid.org/0000-0002-0355-4477Abel Mwebembezihttps://orcid.org/0000-0003-2425-8498Fred M Ssewamalahttps://orcid.org/0000-0002-4849-5650 BackgroundPeople living with HIV often struggle with mental health comorbidities that lower their antiretroviral therapy (ART) adherence. There is growing evidence that depression treatment may improve ART adherence and result in improved HIV outcomes. Given that mental health services are severely underequipped in low-resource settings, including in Uganda, new solutions to increase access to mental health care and close the treatment gap are urgently needed. This protocol paper presents the Suubi-Mhealth study, which proposed to develop a mobile health (mHealth) intervention for use among Ugandan youths (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. ObjectiveThe proposed study is guided by the following objectives: (1) to develop and iteratively refine an intervention protocol for Suubi-Mhealth based on formative work to understand the needs of youths living with HIV; (2) to explore the feasibility and acceptability of Suubi-Mhealth on a small scale to inform subsequent refinement; (3) to test the preliminary impact of Suubi-Mhealth versus a waitlist control group on youths’ outcomes, including depression and treatment adherence; and (4) to examine barriers and facilitators for integrating Suubi-Mhealth into health care settings. MethodsYouths will be eligible to participate in the study if they are (1) 14-17 years of age, (2) HIV-positive and aware of their status, (3) receiving care and ART from one of the participating clinics, and (4) living within a family. The study will be conducted in 2 phases. In phase 1, we will conduct focus group discussions with youths and health care providers, for feedback on the proposed intervention content and methods, and explore the feasibility and acceptability of the intervention. In phase II, we will pilot-test the preliminary impact of the intervention on reducing depression and improving ART adherence. Assessments will be conducted at baseline, 1-, 2-, and 6-months post intervention completion. ResultsParticipant recruitment for phase 1 is completed. Youths and health care providers participated in focus group discussions to share their feedback on the proposed Suubi-Mhealth intervention content, methods, design, and format. Transcription and translation of focus group discussions have been completed. The team is currently developing Suubi-Mhealth content based on participants’ feedback. ConclusionsThis study will lay important groundwork for several initiatives at the intersection of digital therapeutics, HIV treatment, and mental health, especially among sub-Saharan African youths, as they transition through adolescence and into adult HIV care settings. Trial RegistrationClinicalTrials.gov NCT05965245; https://clinicaltrials.gov/study/NCT05965245 International Registered Report Identifier (IRRID)DERR1-10.2196/54635https://www.researchprotocols.org/2024/1/e54635
spellingShingle Proscovia Nabunya
Patricia Cavazos-Rehg
James Mugisha
Erin Kasson
Olive Imelda Namuyaba
Claire Najjuuko
Edward Nsubuga
Lindsey M Filiatreau
Abel Mwebembezi
Fred M Ssewamala
An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
JMIR Research Protocols
title An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
title_full An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
title_fullStr An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
title_full_unstemmed An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
title_short An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
title_sort mhealth intervention to address depression and improve antiretroviral therapy adherence among youths living with hiv in uganda protocol for a pilot randomized controlled trial
url https://www.researchprotocols.org/2024/1/e54635
work_keys_str_mv AT proscovianabunya anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT patriciacavazosrehg anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT jamesmugisha anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT erinkasson anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT oliveimeldanamuyaba anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT clairenajjuuko anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT edwardnsubuga anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT lindseymfiliatreau anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT abelmwebembezi anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT fredmssewamala anmhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT proscovianabunya mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT patriciacavazosrehg mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT jamesmugisha mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT erinkasson mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT oliveimeldanamuyaba mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT clairenajjuuko mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT edwardnsubuga mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT lindseymfiliatreau mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT abelmwebembezi mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial
AT fredmssewamala mhealthinterventiontoaddressdepressionandimproveantiretroviraltherapyadherenceamongyouthslivingwithhivinugandaprotocolforapilotrandomizedcontrolledtrial